TY - JOUR
T1 - A guide for oncologic patient management during covid-19 pandemic
T2 - The initial experience of an Italian oncologic hub with exemplificative focus on uro-oncologic patients
AU - Mistretta, Francesco A.
AU - Luzzago, Stefano
AU - Molendini, Luigi Orlando
AU - Ferro, Matteo
AU - Dossena, Enza
AU - Mastrilli, Fabrizio
AU - Musi, Gennaro
AU - de Cobelli, Ottavio
N1 - Publisher Copyright:
© 2020 by the authors.
Copyright:
Copyright 2020 Elsevier B.V., All rights reserved.
PY - 2020/6
Y1 - 2020/6
N2 - The recent exponential increase in the number of COVID-19 patients in Italy led to the adoption of specific extraordinary measures, such as the need to convey treatment of all non-deferrable cancer patients to specialized centres (hubs). We reported a comprehensive summary of guidelines to create and run an oncologic hub during the COVID-19 pandemic. Oncologic hubs must fulfil some specific requirements such as a high experience in oncologic patient treatment, strict strategies applied to remain a “COVID-19-free” centre, and the creation of a dedicated multidisciplinary “hub team”. Cancer treatment of patients who belong to external centres, namely spoke centres, could be organized in different pathways according to the grade of involvement and/or availability of the medical team of the spoke centre. Moreover, dedicated areas should be created for the management and treatment of patients who developed COVID-19 symptoms after hospitalization (i.e., dedicated wards, operation rooms and intensive care beds). Lastly, hospital staff must be highly trained for both preventing COVID-19 contagion and treating patients who develop the infection. We provided a simplified, but complete and easily applicable guide. We believe that this guide could help those clinicians who have to treat oncologic patients during the COVID-19 pandemic.
AB - The recent exponential increase in the number of COVID-19 patients in Italy led to the adoption of specific extraordinary measures, such as the need to convey treatment of all non-deferrable cancer patients to specialized centres (hubs). We reported a comprehensive summary of guidelines to create and run an oncologic hub during the COVID-19 pandemic. Oncologic hubs must fulfil some specific requirements such as a high experience in oncologic patient treatment, strict strategies applied to remain a “COVID-19-free” centre, and the creation of a dedicated multidisciplinary “hub team”. Cancer treatment of patients who belong to external centres, namely spoke centres, could be organized in different pathways according to the grade of involvement and/or availability of the medical team of the spoke centre. Moreover, dedicated areas should be created for the management and treatment of patients who developed COVID-19 symptoms after hospitalization (i.e., dedicated wards, operation rooms and intensive care beds). Lastly, hospital staff must be highly trained for both preventing COVID-19 contagion and treating patients who develop the infection. We provided a simplified, but complete and easily applicable guide. We believe that this guide could help those clinicians who have to treat oncologic patients during the COVID-19 pandemic.
KW - COVID-19
KW - Medical oncology
KW - Oncology service
KW - SARS-CoV-2
KW - Surgical oncology
UR - http://www.scopus.com/inward/record.url?scp=85086322356&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85086322356&partnerID=8YFLogxK
U2 - 10.3390/cancers12061513
DO - 10.3390/cancers12061513
M3 - Comment/debate
AN - SCOPUS:85086322356
VL - 12
SP - 1
EP - 11
JO - Cancers
JF - Cancers
SN - 2072-6694
IS - 6
M1 - 1513
ER -